K. Groen

Pharmacokinetics of the enantiomers of bupivacaine following intravenous administration of the racemate.

AG Burm, Andries D. van der Meer, JW Van Kleef et al. · British Journal of Clinical Pharmacology · 1994 · 117 citations

Concentrations in plasma and safety of 7 days of intravenous itraconazole followed by 2 weeks of oral itraconazole solution in patients in intensive care units

K. Vandewoude, Dirk Vogelaers, Johan Decruyenaere et al. · Antimicrobial Agents and Chemotherapy · 1997 · 81 citations · Full text

Drug Safety, Oral Itraconazole Solution, Therapeutic Drug Monitoring +12

Bioavailability and disposition of ‘H-solanine in rat and hamster

K. Groen, Diana P.K.H. Pereboom-de Fauw, P. Besamusca et al. · Xenobiotica · 1993 · 18 citations

Prophylactic tocilizumab reduces the incidence of cytokine release syndrome in relapsed/refractory myeloma patients treated with teclistamab: Implications for outpatient step‐up dosing

Charlotte L.B.M. Korst, K. Groen, Patricia W.C. Bosman et al. · HemaSphere · 2024 · 18 citations · Full text

Clinical Immunology, Recurrent Crs, Immunology +23

Ixazomib, daratumumab and low-dose dexamethasone in intermediate-fit patients with newly diagnosed multiple myeloma: an open-label phase 2 trial

K. Groen, Claudia A.M. Stege, Kazem Nasserinejad et al. · EClinicalMedicine · 2023 · 13 citations · Full text